Invest in the Future of IVL

As Featured In

Sign Up and Reserve Your Spot

We opened up opportunities to invest directly into FastWave in 2023 and 2024, and were blown away by the interest from our community. We ended up oversubscribing both fundraises in just a few weeks.

Our next allotment will likely fill up fast, so we encourage you to sign up now to avoid missing out on the next opportunity to invest in FastWave and the future of IVL.

$40M+ raised from corporate venture, VC, and KOLs.

Successful peripheral and coronary FIH procedures.

Only market incumbent acquired by J&J for $13B.

8 patents granted by the USPTO and multiple FTOs.

Led by serial entrepreneurs with multiple exits.

Renowned medical advisory team from elite institutions.

Follow FastWave's Journey

Next-level intravascular lithotripsy (IVL) devices for calcific artery disease.

© 2025 FastWave Medical Inc.

FastWave Medical is developing devices limited by Federal (or United States) law to investigational use. To see FastWave’s patents, click here.

Follow FastWave's Journey

Next-level intravascular lithotripsy (IVL) devices for calcific artery disease.

© 2025 FastWave Medical Inc.

FastWave Medical is developing devices limited by Federal (or United States) law to investigational use. To see FastWave’s patents, click here.

Follow FastWave's Journey

Next-level intravascular lithotripsy (IVL) devices for calcific artery disease.

© 2025 FastWave Medical Inc.

FastWave Medical is developing devices limited by Federal (or United States) law to investigational use. To see FastWave’s patents, click here.

Menu

Menu

Menu